Search research articles
Contact Us
Filters
Showing results (461-470 of 521) with videos related to
Page
of 53
Sort By:
Journal of Hepatocellular Carcinoma
|
June 4, 2024
A Post-International Gastrointestinal Cancers' Conference (IGICC) Position Statements
Suayib Yalcin, Sahin Lacin, Ahmed Omar Kaseb, et al.
Molecular Cancer Therapeutics
|
October 10, 2020
Molecular Characterization of Appendiceal Goblet Cell Carcinoid
Hiroyuki Arai, Yasmine Baca, Francesca Battaglin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 2, 2016
Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Davendra P S Sohal, Pamela B Mangu, Alok A Khorana, et al.
Biomaterials
|
December 4, 2014
The uptake of soluble and nanoparticulate imaging isotope in model liver tumours after intra-venous and intra-arterial administration
Ross W Stephens, Karen J Knox, Lee A Philip, et al.
Molecular Cancer Therapeutics
|
November 2, 2021
Association of Homologous Recombination-DNA Damage Response Gene Mutations with Immune Biomarkers in Gastroesophageal Cancers
Michael Cerniglia, Joanne Xiu, Axel Grothey, et al.
Cancer Research Communications
|
May 16, 2022
Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C-Mutant Cancers
Husain Yar Khan, Misako Nagasaka, Yiwei Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 2021
Randomized Phase II Study of PARP Inhibitor ABT-888 (Veliparib) with Modified FOLFIRI versus FOLFIRI as Second-line Treatment of Metastatic Pancreatic Cancer: SWOG S1513
E Gabriela Chiorean, Katherine A Guthrie, Philip A Philip, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2024
Differential Responses to Immune Checkpoint Inhibitors are Governed by Diverse Mismatch Repair Gene Alterations
Moh'd M Khushman, Michael D Toboni, Joanne Xiu, et al.
JAMA Oncology
|
December 16, 2016
Effect of Selumetinib and MK-2206 vs Oxaliplatin and Fluorouracil in Patients With Metastatic Pancreatic Cancer After Prior Therapy: SWOG S1115 Study Randomized Clinical Trial
Vincent Chung, Shannon McDonough, Philip A Philip, et al.
Future Oncology (London, England)
|
March 28, 2025
S2303: phase II/III trial of paclitaxel + ramucirumab ± nivolumab in gastric and esophageal adenocarcinoma (PARAMUNE)
Anwaar Saeed, Sarah Colby, Paul Eliezer Oberstein, et al.
Page
of 53
Search research articles
Search
Showing results (461-470 of 521) with videos related to
Sort By:
Page
of 53
Journal of Hepatocellular Carcinoma
|
June 4, 2024
A Post-International Gastrointestinal Cancers' Conference (IGICC) Position Statements
Suayib Yalcin, Sahin Lacin, Ahmed Omar Kaseb, et al.
Molecular Cancer Therapeutics
|
October 10, 2020
Molecular Characterization of Appendiceal Goblet Cell Carcinoid
Hiroyuki Arai, Yasmine Baca, Francesca Battaglin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 2, 2016
Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Davendra P S Sohal, Pamela B Mangu, Alok A Khorana, et al.
Biomaterials
|
December 4, 2014
The uptake of soluble and nanoparticulate imaging isotope in model liver tumours after intra-venous and intra-arterial administration
Ross W Stephens, Karen J Knox, Lee A Philip, et al.
Molecular Cancer Therapeutics
|
November 2, 2021
Association of Homologous Recombination-DNA Damage Response Gene Mutations with Immune Biomarkers in Gastroesophageal Cancers
Michael Cerniglia, Joanne Xiu, Axel Grothey, et al.
Cancer Research Communications
|
May 16, 2022
Inhibitor of the Nuclear Transport Protein XPO1 Enhances the Anticancer Efficacy of KRAS G12C Inhibitors in Preclinical Models of KRAS G12C-Mutant Cancers
Husain Yar Khan, Misako Nagasaka, Yiwei Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 2021
Randomized Phase II Study of PARP Inhibitor ABT-888 (Veliparib) with Modified FOLFIRI versus FOLFIRI as Second-line Treatment of Metastatic Pancreatic Cancer: SWOG S1513
E Gabriela Chiorean, Katherine A Guthrie, Philip A Philip, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2024
Differential Responses to Immune Checkpoint Inhibitors are Governed by Diverse Mismatch Repair Gene Alterations
Moh'd M Khushman, Michael D Toboni, Joanne Xiu, et al.
JAMA Oncology
|
December 16, 2016
Effect of Selumetinib and MK-2206 vs Oxaliplatin and Fluorouracil in Patients With Metastatic Pancreatic Cancer After Prior Therapy: SWOG S1115 Study Randomized Clinical Trial
Vincent Chung, Shannon McDonough, Philip A Philip, et al.
Future Oncology (London, England)
|
March 28, 2025
S2303: phase II/III trial of paclitaxel + ramucirumab ± nivolumab in gastric and esophageal adenocarcinoma (PARAMUNE)
Anwaar Saeed, Sarah Colby, Paul Eliezer Oberstein, et al.
Page
of 53